// App-Quantinova.ai

4552 : Long-Term Outcomes of Myeloablative Hematopoietic Cell Transplantation Using Total Body Irradiation Prior to Systemic Therapy

Researchers

Presenter

  • Andrzej Niemierko

Principal Investigators

  • Erin Coughlin

  • Steven L. McAfee

  • Bimalangshu R. Dey

  • Karen K. Ballen

  • Eyal C. Attar

  • Yi-Bin A. Chen

  • Thomas R. Spitzer

  • Karen M. Winkfield

Medical Centers

  • Bone Marrow Transplantation Unit, Massachusetts General Hospital, Boston, MA

Locations

  • United States

Companies

  • N/A

Study Components

Therapeutic Area

  • Oncology (ONC)

Disease

  • Acute lymphoblastic leukemia

  • Chronic Myelogenous Leukemia

  • Acute myelocytic leukemia

  • Hematological malignancies

  • Non-Hodgkin's Lymphoma

  • Non‐Hodgkin Lymphoma

  • Hodgkin's Lymphoma

  • Hypothyroidism

  • Solid malignancies

  • Skin carcinoma

  • Peripheral neuropathy

  • Lymphomas

Biomarkers

  • Breakpoint Cluster Region

  • Hematocrit

  • Tyrosine 3-Monooxygenase/Tryptophan 5-Monooxygenase Activation Protein Epsilon

Drug/Treatment

  • Cyclophosphamide

  • Cyclophosphamide Injection

Outcome

  • N/A

Study Design

  • N/A

Phase

  • NA

Study Id's

  • N/A

Sponsors

  • N/A

Result

  • Interim

Copyright © 2026. QuantiNova All rights reserved